Enrique Aranda

Prognostic Role of <i>KRAS</i> and <i>BRAF</i> in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial

Arnaud Roth, Sabine Tejpar, Mauro Delorenzi et al. · Journal of Clinical Oncology · 2009 · 1.2K citations · Full text

Medicine, Oncology, Surgery +17

Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial

Javier Delgado‐Lista, Juan F. Alcalá‐Díaz, José D. Torres‐Peña et al. · The Lancet · 2022 · 586 citations

Medicine, Nutrition, Preventive Medicine +15

Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3

Eric Van Cutsem, Roberto Labianca, G. Bodoky et al. · Journal of Clinical Oncology · 2009 · 468 citations

Medicine, Oncology, Pharmacology +17

Clinical determinants of survival in patients with 5-fluorouracil- based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients

C.-H. Köhne, David Cunningham, Francesco Di Costanzo et al. · Annals of Oncology · 2002 · 458 citations · Full text

Medicine, Biostatistics, Oncology +12

Phase III Study of Capecitabine Plus Oxaliplatin Compared With Continuous-Infusion Fluorouracil Plus Oxaliplatin As First-Line Therapy in Metastatic Colorectal Cancer: Final Report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial

Eduardo Díaz‐Rubio, Josep Tabernero, Auxiliadora Gómez‐España et al. · Journal of Clinical Oncology · 2007 · 269 citations · Full text

Medicine, Oncology, Pharmacology +11